
Pharmaceutical Value: In the Eye’s of the [Payer] Beholder
Pharmaceutical Value: In the Eye’s of the [Payer] Beholder Susan Hogue In the face of increasing political and financial pressures surrounding the introduction of new
Pharmaceutical Value: In the Eye’s of the [Payer] Beholder Susan Hogue In the face of increasing political and financial pressures surrounding the introduction of new
Unlocking the Key to Successful Medicines Access: Understanding Payer Insights for Pharmaceutical Value Susan Hogue When it comes to developing new medicines, the journey from
Practice Makes Perfect: Preparing for IRA Negotiations Dan Gratie, Jaymin Patel, Chad Patel With the 2026 drug list revealed, pharmaceutical companies must now prepare themselves
Denise Sánchez Palomo and Sissi Pham The Evolution of HCEI/PIE Opportunities- Are you up to Speed? Denise Sánchez Palomo and Sissi Pham Over the last
Chad Patel Finding a safe anchorage in navigating the uncertainties of Inflation Reduction Act (IRA) Chad Patel The Inflation Reduction Act (IRA) passed into US
TEAM AESARA Increased Opportunities to Accelerate Patient Access To Life-Saving Treatments Where are you in your Journey? Chad Patel and Ashik Jayakumar Legislation provisions known